24 withdrawn. 24 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 24 | Withdrawn 24 |
Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities Valbenazine Oral Capsule - Tardive Dyskinesia, Intellectual Disability | Phase 4 | Withdrawn | Stephen Ruedrich | 2025-01-01 | 2024-10-24 | |
| Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department Sublingual film containing dexmedetomidine (BXCL501) - Agitation, Schizophrenia | Phase 4 | Withdrawn | Brigham and Women's Hospital | 2023-09-01 | 2026-01-28 | |
| Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis Polyethylene glycol 3350, Constipation behavioral therapy, Urotherapy - Nocturnal Enuresis | Phase 4 | Withdrawn | Rabin Medical Center | 2020-06-01 | 2018-04-11 | |
| Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder Buprenorphine/Naloxone 8/2 milligram (mg) Sublingual Film, Morphine Sulfate 30 mg - Opioid-use Disorder, Suicidal Ideation | Phase 4 | Withdrawn | New York State Psychiatric Institute | 2020-01-20 | 2021-06-18 | |
| Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract Dysfunction polyethylene glycol 3350, Constipation behavioral therapy, Urotherapy - Diurnal Enuresis | Phase 4 | Withdrawn | Rabin Medical Center | 2020-01-01 | 2018-04-11 | |
| Creatine Monohydrate Use for Preventing Altitude Induced Depression Creatine monohydrate, Placebo - Depression | Phase 4 | Withdrawn | Mike O'Callaghan Military Hospital | 2019-01-01 | 2024-09-19 | |
| Anxiety and Depression in Epilepsy: A Pilot Treatment Study Escitalopram 10mg - Anxiety, Depression | Phase 4 | Withdrawn | Wake Forest University Health Sciences | 2018-05-01 | 2019-09-12 | |
| Creatine for Treatment of Depression Associated With Type 2 Diabetes Creatine Monohydrate - Major Depressive Disorder | Phase 4 | Withdrawn | University of Utah | 2017-08-01 | 2024-06-11 | |
| Intranasal Ketamine for Late-Life Depression and Suicidal Ideation Ketamine, Placebo - Depression, Suicide | Phase 4 | Withdrawn | Massachusetts General Hospital | 2015-07-01 | 2017-03-03 | |
| Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital Ketamine, Haloperidol - Agitation | Phase 4 | Withdrawn | Hennepin Healthcare Research Institute | 2014-04-01 | 2017-07-24 | |
| Evaluation of Naltrexone as a Treatment for Self-injurious Behavior Naltrexone, Placebo - Self-injurious Behavior, Self Mutilation | Phase 4 | Withdrawn | Western Michigan University School of Medicine | 2014-02-22 | 2017-11-06 | |
| Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT Haloperidol, Metoclopramide 10mg, Diphenhydramine - Migraine Headaches, Nausea | Phase 4 | Withdrawn | United States Naval Medical Center, Portsmouth | 2013-06-12 | 2025-07-29 | |
| A Comparative Trial of TMS Approaches to Treating Depression Transcranial Magnetic Stimulation - Depression | Phase 4 | Withdrawn | The University of New South Wales | 2013-06-01 | 2023-04-03 | |
| Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea Bed Alarm, Nasonex - Enuresis, Obstructive Sleep Apnea | Phase 4 | Withdrawn | University of Alberta | 2013-05-01 | 2015-12-18 | |
| Creatine Augmentation in Veterans With SSRI-Resistant Major Depression Creatine - Major Depressive Disorder | Phase 4 | Withdrawn | University of Utah | 2012-09-01 | 2016-08-15 | |
| Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders bupropion, citalopram - Depressive Illness | Phase 4 | Withdrawn | New York State Psychiatric Institute | 2012-06-29 | 2019-03-15 | |
| Lithium Versus Paroxetine in Major Depression Lithium, Paroxetine - Major Depressive Disorder | Phase 4 | Withdrawn | Nova Scotia Health Authority | 2011-09-01 | 2024-09-19 | |
| Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium Risperidone, Trazodone, Placebo - Delirium, Agitation | Phase 4 | Withdrawn | Rochester General Hospital | 2011-03-01 | 2019-09-10 | |
| Ziprasidone vs Standard Therapy for Agitated Patients in the ED ziprasidone, Standard therapy - Psychosis, Agitation | Phase 4 | Withdrawn | George Washington University | 2008-09-01 | 2017-09-25 | |
| Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain Escitalopram, Placebo - Low Back Pain, Depression | Phase 4 | Withdrawn | Martin-Luther-Universität Halle-Wittenberg | 2007-11-01 | 2014-06-17 |
Showing 20 of 24. Sign in to see all of them.
Depression (12) · Psychomotor Agitation (5) · Depressive Disorder, Major (3) · Bipolar Disorder (2) · Constipation (2) · Delirium (2) · Psychotic Disorders (2) · Suicidal Ideation (2) · Alzheimer Disease (1) · Anxiety Disorders (1) · Caregiver Burden (1) · Dementia (1) · Developmental Disabilities (1) · Diabetes Mellitus (1)
Behavior (24) · Mental Disorders (13) · Pathological Conditions, Signs and Symptoms (10) · Signs and Symptoms (9) · Nervous System Diseases (8) · Neurologic Manifestations (7) · Dyskinesias (6) · Neurobehavioral Manifestations (6) · Aberrant Motor Behavior in Dementia (5) · Psychomotor Disorders (5) · Central Nervous System Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4)
Creatine (3) · Citalopram (2) · Escitalopram (2) · Haloperidol (2) · Ketamine (2) · polyethylene glycol 3350 (2) · Buprenorphine (1) · Bupropion (1) · Dexetimide (1) · Diphenhydramine (1) · Fluoxetine (1) · Lithium (1) · Lithium Carbonate (1) · Magnetic Resonance Imaging (1) · Metoclopramide (1)
New York State Psychiatric Institute (2) · Rabin Medical Center (2) · University of Utah (2) · Brigham and Women's Hospital (1) · Creighton University (1) · George Washington University (1) · Hennepin Healthcare Research Institute (1) · Ludwig-Maximilians - University of Munich (1) · Mark Frye (1) · Martin-Luther-Universität Halle-Wittenberg (1) · Massachusetts General Hospital (1) · Mike O'Callaghan Military Hospital (1) · Nova Scotia Health Authority (1) · Rochester General Hospital (1) · Stephen Ruedrich (1)
United States (13) · Canada (2) · Germany (2) · Israel (2) · Australia (1)
Perry F Renshaw, MD, PhD, MBA (2) · Chris A. Karampahtsis, MD, MPH (1) · Claire O'Donovan, MD, FRCPC (1) · Colleen Loo, MB.BS. (Hons), FRANZCP, MD. (1) · Dawn F Ionescu, MD (1) · Heidi Munger Clary, MD (1) · Jonathan W Stewart, MD (1) · Lee Church, MD (1) · Mark A Frye, MD (1) · Matthew Gaffigan, MD (1) · Michael R. Liepman, MD (1) · Mina M Rizk, MD (1) · Mindee S Hite, Pharm.D. (1) · Muhammad Aslam, MD (1) · Oliver Pogarell, MD (1)
PMID 10074879, PMID 10534584, PMID 11110112, PMID 12377400, PMID 17573044, PMID 17880752, PMID 19027962, PMID 20361902, PMID 20439832, PMID 7922470, PMID 8684201, PMID 9474057
2005 (1), 5UL1TR001420-03 (1)